Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Interstitial lung disease pattern recognition on full high resolution computed tomography volume: Development and evaluation of a decision-support tool for less-experimented radiologists.

Diagnostic and interventional imaging·2026
Same author

DECT-based stratification of nonocclusive mesenteric ischemia using bowel-wall iodine concentration: a prospective single-center cohort.

European radiology experimental·2026
Same author

MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.

Journal of hepatology·2026
Same author

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

JHEP reports : innovation in hepatology·2026
Same author

Mesenteric Ischemia: 2026 Update-<i>AJR</i> Expert Panel Narrative Review.

AJR. American journal of roentgenology·2026
Same author

Source control following traumatic gastric perforation : not so easy.

Intensive care medicine·2026
Same journal

Integrated multiclass driver ctDNA profiling enables MPNST detection and monitoring in NF1 patients.

NPJ precision oncology·2026
Same journal

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

NPJ precision oncology·2026
Same journal

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

NPJ precision oncology·2026
Same journal

Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.

NPJ precision oncology·2026
Same journal

Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.

NPJ precision oncology·2026
Same journal

Anatomically constrained deep learning for clinical-grade volumetric pancreatic cancer segmentation: development, validation, and architectural benchmarking.

NPJ precision oncology·2026
查看所有相关文章

相关实验视频

Updated: May 10, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K

一个快速的CT基础模型用于实体瘤评估.

Léo Machado1,2, Léo Alberge1, Hélène Philippe1,2,3

  • 1Raidium, Paris Biotech Santé, Paris, France.

NPJ precision oncology
|April 25, 2025
PubMed
概括
此摘要是机器生成的。

一个交互式AI工具ONCOPILOT增强了瘤细分和使用CT扫描进行RECIST 1.1评估. 它提高了瘤学研究和临床决策的准确性和效率.

更多相关视频

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.8K
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.6K

相关实验视频

Last Updated: May 10, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.8K
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.6K

科学领域:

  • 在瘤学瘤学.
  • 人工智能的人工智能
  • 医疗成像医学成像

背景情况:

  • 癌症是复杂的,导致异质瘤的结果变化.
  • 目前的瘤评估方法,如RECIST 1.1,是劳动密集型和易出错的.
  • 现有的AI解决方案与瘤异质性作斗争,缺乏用户交互.

研究的目的:

  • 开发一个用于3D瘤细分和RECIST 1.1评估的交互式AI工具.
  • 为了完善纵向瘤评估与放射科医生的参与.
  • 通过先进的人工智能改进临床决策和瘤学研究.

主要方法:

  • 开发了ONCOPILOT,这是一个基于CT的交互式基础模型,用于3D瘤细分.
  • 利用直观的视觉提示 (点击,界限框,编辑点) 进行放射科医生的交互.
  • 在8000多次CT扫描中训练了模型.

主要成果:

  • ONCOPILOT实现了与最先进的方法相比或超过的细分精度.
  • 为RECIST 1.1测量提供了放射科医生级别的精度,减少了观察者之间的变化.
  • 提高了工作流程的效率,并促进了对体积瘤分析的访问.

结论:

  • 交互式人工智能,就像ONCOPILOT一样,显著改进了RECIST 1.1评估.
  • 该工具支持改善患者分层和临床决策.
  • 通过整合人工智能和临床专业知识,ONCOPILOT加速了瘤学研究的进步.